MDMA/FDA meeting

Executive Summary

Medical Device Manufacturers Association President Larry Holden and Director of Federal Affairs Mark Leahey plan to meet with FDA Acting Commissioner Lester Crawford and CDRH Director David Feigal June 4. Among probable discussion topics are a device user fee proposal negotiated by trade group AdvaMed and FDA. The proposal was recently excluded from bioterrorism legislation but could still be reconsidered by Congress this session along with Greenwood/Eshoo device reforms (1"The Gray Sheet" May 27, 2002, p. 3)...